Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Non-interventional, Multicenter Study to Investigate the Prevalence of HER2 IHC 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan -The HERGYN Study

NCT06925113 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT06925113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06925113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Non-interventional, Multicenter Study to Investigate the Prevalence of HER2 IHC 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan -The HERGYN Study
Lead sponsor
Daiichi Sankyo
Phase
Observational
Overall status
Completed
Start date
January 31, 2025
Completion date
September 26, 2025
Enrollment
509 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancers, endometrial cancer, ovarian cancer